Crozet BioPharma

Crozet BioPharma is a privately held, pre-revenue service provider in the biopharmaceutical sector, operating as a specialized contract development organization (CDO) for vaccine and biologic development. The company leverages over 200 years of combined senior leadership experience to offer end-to-end program management, from preclinical research through clinical trials and regulatory submissions, primarily in oncology and infectious disease immunology. Its business model is built on providing an outsourced, expert team to biopharma sponsors, thereby reducing their internal resource burden and development risk. With a seasoned team that includes former FDA regulators and industry veterans, Crozet positions itself as a high-caliber partner for advancing complex biological products.

Integrated service model leveraging over 200 years of combined team expertise across the full vaccine/biologic development lifecycle, including project management, process development, manufacturing support, analytical development, clinical operations, and regulatory affairs.

Crozet competes in the broad contract development and manufacturing organization (CDMO) space, but differentiates through its focus on vaccines/immunology and its exceptionally senior, integrated team. It faces competition from large, global CDMOs with greater scale and from smaller niche consultants, but its full-service, partner-level engagement model is a distinct positioning.